News from PTC Therapeutics, Celgene and Heron Therapeutics

PTC Therapeutics (PTCT) stock, which dipped yesterday, probably on news announcing a public offering of 4,000,000 shares of its common stock at a public offering price of $27.04 per share.

Yesterday, in a crazy market that looked as if the bull and bear are boxers knocking each other down every 10 minutes, PTCT lost around $5. The stock seems to rebound in today’s premarket trading.

Another probable reason for the stock’s selloff could be the good news we posted yesterday . . .

This content is for paid subscribers.
Please click here to subscribe or here to log in.